Co-Infusion of Allogeneic Cord Blood with Haploidentical CD34+ Cells Improved Transplant Outcome for Patients with Severe Aplastic Anemia Undergoing Cord Blood Transplantation
Nicole Gormley(United States Food and Drug Administration), Richard Childs(National Heart Lung and Blood Institute), Catalina Ramos(National Institutes of Health), Sawa Ito(National Institutes of Health), Sophie Grasmeder(National Institutes of Health), Hahn Khuu(National Institutes of Health Clinical Center), Jeremy Pantin(National Institutes of Health), David F. Stroncek(Yale University), Minoo Battiwalla(Sarah Cannon), Jennifer Wilder(Science Applications International Corporation (United States)), Robert Reger(National Institutes of Health), Sharon Adams(National Institutes of Health Clinical Center), Patricia Prince(National Institutes of Health Clinical Center), Maria Berg(National Institutes of Health), Lisa Cook(National Institutes of Health), Theresa Donohue(National Institutes of Health), Charles D. Bolan(National Institutes of Health), Willy A. Flegel(National Institutes of Health Clinical Center), A. John Barrett(National Heart Lung and Blood Institute), Roger Kurlander(National Institutes of Health Clinical Center)
Cited by 15
Related Papers
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331
RHD gene deletion occurred in the Rhesus box
|Blood|2000|319
RHD positive haplotypes in D negative Europeans
|BMC Genetics|2001|310